- Knee Osteoarthritis
- Hip Osteoarthritis
- Shoulder Osteoarthritis
- Ankle Osteoarthritis
The global hyaluronic acid viscosupplementation market is expected to reach at US$ 4539.81 million in market and growing at a CAGR of 6.1% over the forecast period by 2028. The key drivers are considered to be increase in number of people with osteoarthritis, obese population due to the change in lifestyle and geriatric population contributing towards the growth of global hyaluronic acid viscosupplementation market. The key challenges include lack of safety and efficacy and complex regulatory process because reimbursement policies of different countries are independent of each other there are a considerable number of pipeline drugs waiting for approval. Demand for non-surgical method and high lifestyle related diseases open up a huge market for global market. Osteoarthritis is treated using a method called viscosupplementation. Because there is no treatment for arthritis, viscosupplementation is used to help the condition better. It is a viscous fluid called hyaluronate that is injected into the body to help support the synovial fluid's lubricating characteristics. As a result, it lessens the discomfort associated with osteoarthritis of the knee, improves mobility, and provides a more comfortable level of exercise. This is only utilised when other treatment options have been exhausted and failed to help with the management. The market is fueled by major factors such as an increase in the number of individuals suffering from osteoarthritis, which is expected to move the industry forward. The market is expected to grow throughout the projected period as people become more aware of the new treatments available for osteoarthritis management.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
It is noticed that the global hyaluronic acid viscosupplementation market is influenced mainly by the number of osteoarthritis patients which is the key factor causing the hyaluronic acid viscosupplementation market to grow. According to WHO (World Health Organization) 18% women and 9.6% men over the age of 60 years suffer from Osteoarthritis among this 25% cannot participate in the daily activities and 80% have very contracted resisted movements. Key factors contributing this is unhealthy lifestyle due to the overweight the joint get weakened and effect the movements other one is old age group the bones and join get weakened which hinder the mobility hence contributing the high growth in global hyaluronic acid viscosupplementation market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.